|
|
Vaccine Detail
|
GRAd-CoV2 |
| Vaccine Information |
- Vaccine Name: GRAd-CoV2
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Manufacturer: ReiThera
- Vaccine Ontology ID: VO_0005169
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Antigen: SARS-CoV-2 S protein (NCT04528641)
- Immunization Route: Intramuscular injection (i.m.)
- Description: A SARS-CoV 2 recombinant viral vector using Gorilla Adenovirus that encodes for SARS-CoV-2 Spike protein.
(NCT04528641)
|
| Host Response |
|
|
| References |
NCT04528641: GRAd-COV2 Vaccine Against COVID-19 [https://www.clinicaltrials.gov/ct2/show/NCT04528641?term=GRAd-COV2&draw=2&rank=1]
|
|
